(Q38076051)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23340856%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

review article

1 reference

title

From bone abnormalities to mineral metabolism dysregulation in autosomal dominant polycystic kidney disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23340856%20AND%20SRC:MED&resulttype=core&format=json

autosomal dominant polycystic kidney disease

22 February 2020

main subject

1 reference

autosomal dominant polycystic kidney

inferred from title

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23340856%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Djalila Mekahli

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23340856%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

publication date

24 January 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23340856%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23340856%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23340856%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23340856%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

2089-2096

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23340856%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00467-012-2384-5

22 February 2020

exact match

0 references

cites work

Polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Autosomal dominant polycystic kidney disease: the last 3 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Update on fibroblast growth factor 23 in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Patients with autosomal dominant polycystic kidney disease have elevated fibroblast growth factor 23 levels and a renal leak of phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Soluble klotho and autosomal dominant polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Normal values for renal length and volume as measured by magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Characteristics of hypertension in young adults with autosomal dominant polycystic kidney disease compared with the general U.S. population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Autosomal dominant polycystic kidney disease--more than a renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Clinical practice. Autosomal dominant polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Renal asymmetry in children with autosomal dominant polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Treatment of autosomal dominant polycystic kidney disease (ADPKD): the new horizon for children with ADPKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Perinatal deaths in a family with autosomal dominant polycystic kidney disease and a PKD2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

The primary cilium in cell signaling and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

A physiological view of the primary cilium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Functional coordination of intraflagellar transport motors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Intraflagellar transport is required for the vectorial movement of TRPV channels in the ciliary membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

A septin diffusion barrier at the base of the primary cilium maintains ciliary membrane protein distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

The primary cilium: a signalling centre during vertebrate development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Cyclic nucleotide signaling in polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

The renal cell primary cilium functions as a flow sensor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Bending the MDCK cell primary cilium increases intracellular calcium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Role of the polycytin-primary cilia complex in bone development and mechanosensing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Ciliary polycystin-2 is a mechanosensitive calcium channel involved in nitric oxide signaling cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Endothelial cilia are fluid shear sensors that regulate calcium signaling and nitric oxide production through polycystin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Cardiovascular, skeletal, and renal defects in mice with a targeted disruption of the Pkd1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

TRPCs, GPCRs and the Bayliss effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Transient receptor potential (TRP) channels, vascular tone and autoregulation of cerebral blood flow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Cilia-like structures and polycystin-1 in osteoblasts/osteocytes and associated abnormalities in skeletogenesis and Runx2 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Polycystin-1 regulates skeletogenesis through stimulation of the osteoblast-specific transcription factor RUNX2-II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Conditional deletion of Pkd1 in osteocytes disrupts skeletal mechanosensing in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Somatic mutation in individual liver cysts supports a two-hit model of cystogenesis in autosomal dominant polycystic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Diagnosis of autosomal dominant polycystic kidney disease in utero and in the young infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Molecular genetic diagnosis of autosomal dominant polycystic kidney disease in a newborn with bilateral cystic kidneys detected prenatally and multiple skeletal malformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Oral-facial-digital syndrome type 1 is another dominant polycystic kidney disease: clinical, radiological and histopathological features of a new kindred.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

The oral-facial-digital syndrome type 1 (OFD1), a cause of polycystic kidney disease and associated malformations, maps to Xp22.2-Xp22.3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Further evidence that the Hajdu-Cheney syndrome and the "serpentine fibula-polycystic kidney syndrome" are a single entity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Serpentine fibula polycystic kidney syndrome is part of the phenotypic spectrum of Hajdu-Cheney syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Primary cilia in the pathogenesis of dentigerous cyst: a new hypothesis based on role of primary cilia in autosomal dominant polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

How fibroblast growth factor 23 works

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Anti-FGF23 neutralizing antibodies show the physiological role and structural features of FGF23.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Mineralized tissue cells are a principal source of FGF23.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Does FGF23 toxicity influence the outcome of chronic kidney disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25-dihydroxyvitamin D in human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

The Klotho gene family as a regulator of endocrine fibroblast growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Initial FGF23-mediated signaling occurs in the distal convoluted tubule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

The beta-glucuronidase klotho hydrolyzes and activates the TRPV5 channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

FGF-23: More than a regulator of renal phosphate handling?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Latest findings in phosphate homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Relationship between circulating FGF23 and total body atherosclerosis in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Role of fibroblast growth factor 23 in health and in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Elevated FGF 23 and phosphorus are associated with coronary calcification in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

FGF23 induces left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Gene expression analysis of kidneys from transgenic mice expressing fibroblast growth factor-23.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Establishment of sandwich ELISA for soluble alpha-Klotho measurement: Age-dependent change of soluble alpha-Klotho levels in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2384-5

Serpentine fibula-polycystic kidney syndrome caused by truncating mutations in NOTCH2

21 January 2018

1 reference

12 December 2020

Left ventricular hypertrophy in autosomal dominant polycystic kidney disease

1 reference

12 December 2020

Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort

1 reference

12 December 2020

The parathyroid is a target organ for FGF23 in rats

1 reference

12 December 2020

Polycystin-1 and -2 Dosage Regulates Pressure Sensing

1 reference

12 December 2020

Synthesis of renin by tubulocystic epithelium in autosomal-dominant polycystic kidney disease

1 reference

12 December 2020

Pathogenesis of hypertension in autosomal dominant polycystic kidney disease

1 reference

12 December 2020

Autosomal dominant polycystic kidney disease in childhood: a longitudinal study

1 reference

12 December 2020

The role of parental hypertension in the frequency and age of diagnosis of hypertension in offspring with autosomal-dominant polycystic kidney disease

1 reference

12 December 2020

Prenatal sonographic patterns in autosomal dominant polycystic kidney disease: a multicenter study

1 reference

12 December 2020

Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community

1 reference

12 December 2020

Autosomal dominant polycystic kidney disease

1 reference

12 December 2020

Early renal abnormalities in children with postnatally diagnosed autosomal dominant polycystic kidney disease

1 reference

12 December 2020

Bilateral "hereditary" polycystic disease of the kidneys associated with bilateral teratodactyly of the feet

1 reference

12 December 2020

The influence of glomerular filtration rate and age on fibroblast growth factor 23 serum levels in pediatric chronic kidney disease

1 reference

12 December 2020

Comparison of Pkd1-targeted mutants reveals that loss of polycystin-1 causes cystogenesis and bone defects

1 reference

12 December 2020

Causes of death in autosomal dominant polycystic kidney disease

1 reference

12 December 2020

Polycystins under pressure

1 reference

12 December 2020

Factors relating to urinary protein excretion in children with autosomal dominant polycystic kidney disease.

1 reference

12 December 2020

Renal structure and hypertension in autosomal dominant polycystic kidney disease

1 reference

12 December 2020

Pelvic insufficiency fracture related to autosomal dominant polycystic kidney disease

1 reference

12 December 2020